After a systematic review of all publications on recurrent pericarditis from 1966 to 2006, we identified 8 major clinical series including a total of 230 patients with idiopathic recurrent pericarditis (mean age 46 years, men/women ratio: 0.9). After a mean follow-up of 61 months, the complication rate was 3.5% cardiac tamponade and 0% constrictive pericarditis and left ventricular dysfunction. The overall life prognosis is excellent in idiopathic recurrent pericarditis and complications are uncommon. In conclusion constrictive pericarditis was never reported despite numerous recurrences, and the risk is lower than in idiopathic acute pericarditis (approximately 1%). Thus, it is important to reassure patients on their prognosis, explaining the nature of the disease, and the likely course. Therapeutic choices should take into account of the overall good outcome of these patients, including less toxic agents.

Prognosis of Idiopathic Recurrent Pericarditis as Determined from Previously Published Reports / M. Imazio, A. Brucato, Y. Adler, G. Brambilla, G. Artom, E. Cecchi, G. Palmieri, R. Trinchero. - In: THE AMERICAN JOURNAL OF CARDIOLOGY. - ISSN 0002-9149. - 100:6(2007), pp. 1026-1028.

Prognosis of Idiopathic Recurrent Pericarditis as Determined from Previously Published Reports

A. Brucato;
2007

Abstract

After a systematic review of all publications on recurrent pericarditis from 1966 to 2006, we identified 8 major clinical series including a total of 230 patients with idiopathic recurrent pericarditis (mean age 46 years, men/women ratio: 0.9). After a mean follow-up of 61 months, the complication rate was 3.5% cardiac tamponade and 0% constrictive pericarditis and left ventricular dysfunction. The overall life prognosis is excellent in idiopathic recurrent pericarditis and complications are uncommon. In conclusion constrictive pericarditis was never reported despite numerous recurrences, and the risk is lower than in idiopathic acute pericarditis (approximately 1%). Thus, it is important to reassure patients on their prognosis, explaining the nature of the disease, and the likely course. Therapeutic choices should take into account of the overall good outcome of these patients, including less toxic agents.
Relapsing pericarditis; therapy; colchicine; management; efficacy; diseases; outcomes; trial
Settore MED/09 - Medicina Interna
2007
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0002914907011836-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 63.35 kB
Formato Adobe PDF
63.35 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/637399
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 90
  • ???jsp.display-item.citation.isi??? 77
social impact